Jump to any asset
849 assets, updated daily
As of September 26, 2026, The Cigna Group (CI) trades at $272.01. CleaRank Financial AI rates it Hold with a fair value of $340.00, 25.0% above the current price. Wall Street's consensus target is $340.00 across 25 analysts. RSI at 40 is in neutral territory, and the price is below its 50-day average of $280.36.
The Cigna Group (CI)
The Cigna Group NYSE
$272.01
6.510 (2.45%)
At close: Sep 25, 4:00 PM EDT
AI Analyst Consensus
55 / 100
The Cigna Group (CI) is currently trading at $272.01, below its 50-day and 200-day moving averages ($280.36 and $279.91), signaling a bearish technical trend. Despite this, the median Wall Street price target of $340.00 suggests a potential upside of 25.0%. The company operates in the Healthcare Plans industry, a sector with a median P/E of 31.9 and revenue growth of 8.1%. However, recent insider activity reveals heavy net selling, with over $77 million in sales versus less than $1 million in purchases, contributing to a 'Heavy Sell Signal' verdict. This, combined with a bearish RSI status, suggests caution despite the analyst consensus leaning towards 'Buy'. The company's fundamentals show a profit margin of 2.27% and a return on equity of 16.76%, which appears reasonable relative to its sector, but the significant insider divestitures warrant close monitoring.
CI Price Analysis
Market Metrics
Open
$266.13
Day Range
$265.35 to $273.36
Prev Close
$265.50
Volume
1.82M
52-Week Range
$239.51 to $315.47
Market Cap
$71.88B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Trading at a notable discount to sector peers (-65%), which may indicate undervaluation or specific company headwinds.
CI Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 2 quarters, CI beat estimates 2 times. The stock rose 2 times the next day. Price tends to react positively to beats.
CI Analysis
Company's Health
3/5
12-Month Analyst Target
+25.00% Upside
Median of 25 analysts (12-month)
$340.00
AI Technical Analysis
The Cigna Group (CI) is trading below its 50-day and 200-day moving averages ($280.36 and $279.91), indicating a bearish trend. The Relative Strength Index (RSI) at 39.95 is in bearish territory, suggesting weakening momentum. Volume on the latest trading day was 1.82 million, 18.6% above the average, which could indicate increased selling pressure. The MACD at -2.76 also points to a bearish short-term outlook. Key support levels are not clearly defined by long-term averages, but the current price action suggests a downward bias until these averages are reclaimed.
ProTips
- Monitor insider transactions closely, as the current heavy selling pressure from insiders may indicate near-term headwinds for The Cigna Group (CI).
- The Cigna Group (CI) is trading below its 50-day and 200-day moving averages ($280.36 and $279.91), suggesting a bearish technical trend; consider waiting for a confirmed break above these levels before initiating new positions.
- Given the current bearish technicals and insider selling, risk management is paramount. Consider tighter stop-loss levels or reducing position size until a clearer bullish trend emerges.
Key Catalysts
Bearish
Heavy Insider Selling Pressure
Insiders have sold over $77 million worth of The Cigna Group (CI) stock, significantly outweighing purchases of less than $1 million, leading to a 'Heavy Sell Signal'.
Source: Insider Trading DataBearish
Below Key Moving Averages
The Cigna Group (CI) is trading below its 50-day and 200-day moving averages ($280.36 and $279.91), indicating a bearish technical trend and potential for further price declines.
Source: Technical AnalysisBullish
Median Analyst Price Target Upside
The median Wall Street price target for The Cigna Group (CI) is $340.00, representing a potential upside of 25.0% from the current price of $272.01.
Source: Wall Street ConsensusBullish
Attractive Valuation Metrics
The Cigna Group (CI) trades at a P/E of 11.32 and P/S of 0.25, significantly below sector medians, suggesting potential undervaluation.
Source: Fundamental AnalysisMarket Outlook
The Cigna Group (CI) faces a mixed outlook, with a median Wall Street price target of $340.00 suggesting potential upside from the current $272.01. The company's forward revenue growth is estimated at around 4.00% for the upcoming quarters and years, with a projected 5-year compound annual growth rate of approximately 10.03%. The current valuation appears attractive relative to sector averages, supported by solid profitability metrics. However, the significant insider selling pressure and bearish technical indicators present considerable near-term risks. A failure to reclaim key moving averages could lead to further downside, potentially testing lower support levels. Positive catalysts would need to overcome the current insider sentiment and technical weakness to drive a sustained rally towards analyst targets.
Key Statistics
| Market Cap | 71.88B |
|---|---|
| P/E Ratio | 11.32 |
| EPS (TTM) | 23.69 |
| Dividend Yield | 2.27% |
| 52 Week High | 315.47 |
| 52 Week Low | 239.51 |
The Cigna Group (CI) exhibits a P/E ratio of 11.32, significantly lower than the healthcare sector median of 31.9, suggesting a potentially attractive valuation. Its price-to-sales ratio of 0.25 is also well below the sector average of 3.7. The company's profit margin stands at 2.27% and its return on equity is 16.76%, which is strong compared to the sector's median ROE of 6.9%. Despite the favorable valuation metrics and solid profitability, the substantial insider selling activity raises concerns about management's near-term confidence. The company's debt-to-equity ratio of 0.74 is in line with the sector average, indicating a manageable leverage position. The current valuation appears to discount near-term headwinds, but the heavy insider selling warrants careful consideration.
Earnings & Growth Analysis
The Cigna Group (CI) reported mixed recent earnings results. For the quarter to June 2026, the company posted an actual EPS of -$0.02 against an estimate of $0.04, a surprise of -150%, with the stock reacting positively with a 0.57% gain. Prior to that, for the quarter to June 2026, EPS was -$0.09 versus an estimate of -$0.33, a 72.73% surprise, and the stock rose 1.07%. The company has shown inconsistency in beating earnings estimates, with only one beat points.
Key Risks
The primary risk for The Cigna Group (CI) stems from significant insider selling, with over $77 million in dispositions, signaling potential negative sentiment from management. The stock is also trading below key moving averages, indicating bearish technical momentum. Also, recent earnings have shown inconsistency, with a notable miss in the latest reported quarter.
Technical Indicators
| RSI (14) | 39.95 |
|---|---|
| MACD | -2.76 |
| SMA 50 | 280.36 |
| SMA 200 | 279.91 |
RSI
Bearish
SMA Cross
Neutral
Price vs SMA
Bearish
MACD
Bearish
Price is trading below the 50-day SMA.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.08
Weak correlation
Nasdaq 100 (QQQ)
-0.02
Weak correlation
Bitcoin (BTC)
+0.00
Weak correlation
Gold (XAU)
-0.01
Weak correlation
Check Custom Correlation
How does any other asset move with CI? One year of daily closes, Pearson correlation.
Try
CI Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies pick an entry style
Conservative
$269.29
Slight discount to current
Wait for small dip
Aggressive
$272.01
At current price
Enter now if confident
Risk Management
STOP LOSS
$257.09
MAX LOSS
-4.5%
Volatility-Adjusted Stop Loss
Calculated based on RSI (40.0) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$277.37
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$282.75
+5% (Conservative)
+3.9% (Aggressive)
TARGET 3
$290.83
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for CI is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 26, 2026.Growth of $10,000
A $10,000 investment in CI in September 2016 would be worth about $20,869 today, compared with about $36,004 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CI today could grow to about $20,458 by 2036 in the base case, with a bull case near $71,518 and a bear case around $5,852. Projections are statistical simulations, not guarantees.
CI Stock Price Prediction: 2030
CleaRank's simulation projects a price near $362 for CI by 2030 in the base case, from $272 today (1.3x over 4 years). The downside path ends near $164. These are outcomes of a Monte Carlo simulation run on CI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $197 | $292 | $434 |
| 2028 | $179 | $314 | $549 |
| 2029 | $170 | $337 | $669 |
| 2030 | $164 | $362 | $799 |
| 2031 | $161 | $389 | $943 |
| 2032 | $159 | $418 | $1,102 |
| 2033 | $158 | $449 | $1,279 |
| 2034 | $157 | $482 | $1,477 |
| 2035 | $158 | $518 | $1,698 |
| 2036 | $159 | $556 | $1,945 |
Method: 10,000 simulated price paths using CI's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
CI Insider Trading Analysis
Bought
$999.9K
1 Transactions
Sold
$77.0M
9 Transactions
Insiders
18
Active Traders
Avg Transaction
$7.8M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 12, 2026 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 201.9K | $59.1M |
| Jun 8, 2020 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 203.1K | $42.7M |
| Apr 15, 2021 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 130.4K | $33.1M |
| May 7, 2021 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 62.1K | $16.2M |
| Mar 25, 2024 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 39.8K | $14.1M |
| Feb 12, 2024 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 40.1K | $13.5M |
| Jan 21, 2021 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 55.2K | $12.7M |
| Jan 12, 2021 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 55.3K | $12.4M |
| May 17, 2022 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 45.3K | $12.2M |
| Apr 20, 2022 | CORDANI DAVID M
Chief Executive Officer
|
Sell | 45.4K | $12.2M |
Page 1 of 1
Frequently Asked Questions
Is The Cigna Group stock a buy right now?
The Cigna Group (CI) is currently rated a 'Hold' with a consensus score of 55. While the median Wall Street price target of $340.00 suggests potential upside from the current price of $272.01, significant insider selling and bearish technical indicators warrant caution.
What is CI's stock price forecast for 2030?
Based on Monte Carlo simulations, The Cigna Group's (CI) stock price forecast for 2030 includes a base case of $362.18, a downside projection of $164.12, and an upside scenario of $799.28. These are statistical outcomes, not guarantees.
How does The Cigna Group's valuation compare to its sector?
The Cigna Group (CI) trades at a P/E ratio of 11.32 and a price-to-sales ratio of 0.25, which are significantly lower than the healthcare sector medians of 31.9 and 3.7, respectively, suggesting a potentially undervalued stock relative to its peers.
What is the recent earnings performance of The Cigna Group?
The Cigna Group (CI) reported a significant earnings miss for the quarter to June 2026, with an actual EPS of -$0.02 against an estimate of $0.04. While the stock saw a positive reaction, this follows a pattern of inconsistent earnings beats.
Are insiders buying or selling The Cigna Group stock?
Insiders at The Cigna Group (CI) are net sellers, with total sales exceeding $77 million compared to less than $1 million in purchases. This heavy selling pressure has resulted in a 'Heavy Sell Signal' verdict.
What are the key technical indicators for CI stock?
The Cigna Group (CI) is showing bearish technical signals, trading below its 50-day and 200-day moving averages ($280.36 and $279.91), with an RSI at 40.0 indicating weakening momentum and a MACD of -2.76.
What is the outlook for The Cigna Group's revenue growth?
The Cigna Group (CI) is projected to achieve revenue growth of approximately 4.00% for the current quarter and next quarter, with similar growth expected for the current and next year. Long-term growth estimates are around 10% annually over the next five years.